Intra-Cellular Therapies ITCI

Annual report 2024
added 02-21-2025

Intra-Cellular Therapies DIO Ratio 2011-2026 | ITCI

Quarterly DIO Ratio Intra-Cellular Therapies

2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	4.67 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
4.67 K	4.67 K	4.67 K

DIO Ratio of other stocks in the Biotechnology industry

	Issuer	DIO Ratio	Price	% 24h	Market Cap	Country
	Acorda Therapeutics ACOR	345	-	-24.86 %	$ 820 K	USA
	Acasti Pharma ACST	136	-	4.01 %	$ 150 M	Canada
	Alexion Pharmaceuticals, Inc. ALXN	512	-	-	$ 40.3 B	USA
	Albireo Pharma ALBO	26.1	-	-0.23 %	$ 916 M	USA
	Aptorum Group Limited APM	4.89	$ 0.8	1.81 %	$ 4.36 M	China
	Midatech Pharma plc MTP	40.6	-	-18.52 %	$ 27.3 M	Britain
	BioCardia BCDA	4.08	$ 1.35	6.29 %	$ 28.6 M	USA
	Институт стволовых клеток человека ISKJ	275	-	-	-	Russia
	Aeterna Zentaris AEZS	55.6	-	5.93 %	$ 314 M	Canada
	Catalyst Biosciences CBIO	201	$ 11.29	-2.51 %	$ 1.01 B	USA
	Anika Therapeutics ANIK	247	$ 14.58	1.53 %	$ 214 M	USA
	AVEO Pharmaceuticals AVEO	63.8	-	-	$ 521 M	USA
	Aytu BioScience AYTU	209	$ 2.69	1.7 %	$ 16.9 M	USA